Replacing Legacy Systems at Scale: Bayer's Global Migration to the CARA Platform

This is a thin landing page rather than a full case study: it states Bayer migrated approximately 900,000 regulatory documents and 85,000 users off the legacy Documentum system onto Generis's cloud-based CARA platform, as a strategic infrastructure modernization. Beyond the scope figures (documents and user count), the visible page gives no further problem detail, implementation narrative, or additional quantified outcomes -- the full case study is only available as a separate downloadable document that was not part of the fetched page.

Generis makes the CARA platform, the regulatory/quality/clinical content backbone used by major pharma companies, now with AI document-classification features built in.

This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.